Is RGEN a good stock to buy? We came across a bullish thesis on Repligen Corporation on R. Dennis’s Substack by OppCost. In ...

Biolife Solutions Inc. has attracted takeover interest from parties including diagnostics company Repligen Corp., according ...

Repligen Corporation (NASDAQ:RGEN) defied analyst predictions to release its third-quarter results, which were ahead of market expectations. The company beat both earnings and revenue forecasts, with ...

View Repligen Corporation RGEN stock quote prices, financial information, real-time forecasts, and company news from CNN.

Brown Capital Management, an investment management company, released its first quarter 2026 investor letter for “The Brown Capital Management Small Company Fund”. A copy of the letter can be ...

Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) reported Q1 CY2026 results topping the market’s revenue ...

The Strategy fell 7.72% (net) in the quarter compared to -6.35% for the Russell Midcap Growth Index. In the first quarter, ...

WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating in ...

Repligen Corporation has acquired 908 Devices' desktop portfolio, which includes four analytical devices for bioprocessing applications, for $70 million in cash. This acquisition enhances Repligen's ...

On Tuesday, Repligen Corporation (NASDAQ:RGEN) purchased 908 Devices Inc.’s (NASDAQ:MASS) desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications. The ...

Brown Capital Management, an investment management company, released its first quarter 2026 investor letter for “The Brown ...